Health Care·Health Care Services·$21.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.33 | N/A | +13.19% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.33 | N/A | +13.19% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to improve operational efficiency.
Quest Diagnostics reported a strong earnings per share, exceeding expectations, which contributed to a 6.03% increase in stock price. The positive surprise in EPS indicates that the company is managing its costs effectively, but the lack of revenue details leaves some uncertainty. Investors may view this as a sign of resilience in the company's operations.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BROWN & BROWN INC
Apr 17, 2017